What is FEMARA® (letrozole tablets)?
FEMARA is a convenient, once-a-day oral prescription therapy. FEMARA is approved for the adjuvant treatment (after surgery) of postmenopausal women with hormone receptor-positive early stage breast cancer. The benefits of FEMARA in clinical trials are based on 24 months of treatment. Further follow-up will be needed to determine long-term results. FEMARA is also approved for the extended adjuvant treatment of early stage breast cancer in postmenopausal women who are within three months of completion of five years of tamoxifen therapy. The benefits of FEMARA in the clinical trial are based on 24 months of treatment. Further follow-up will be needed to determine long-term results, including side effects.